North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Obinutuzumab
found
6 matches
Open monograph to display formulary status
BNF Category
Obinutuzumab
Malignant disease and immunosuppression - Anti-lymphocyte monoclonal antibodies - 08.02.03
Links
Link to Drug Section
Link to document
NHSE Clinical Commissioning Policy: Obinutuzumab elective therapy to prevent immune Thrombotic Thrombocytopenic Purpura (TTP) relapse in patients who are refractory or intolerant to rituximab (adults) (08.02.03)
NICE TA343: Obinutuzumab with chlorambucil for CLL (08.02.03)
NICE TA629: Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab (08.02.03)
NICE TA663 Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia (08.01.05)
NICE TA978: Zanubrutinib with obinutuzumab for treating relapsed or refractory B-cell follicular lymphoma after 2 or more treatments (terminated appraisal) (08.01.05)
